CCL2 and invasive ductal breast carcinoma: To characterize CCL2 expression in invasive ductal carcinomas (IDCs), Valkovic et al. [29] first evaluated the expression of CCL2 in the parenchymal and stromal cells of 27 IDC cases (Table 1).